All patients who met the current criteria for GLP1-RA treatment and were prescribed with semaglutide, either in the oral or injective formulation, from October 2021 to October 2022, were enrolled in the study
Key Facts About CPT 90715 Service type: Vaccine product Provider type: Physicians, clinics, pharmacies, and qualified healthcare professionals Medical services included: YesTdap vaccine supply Route of administration: Intramuscular (IM) Age range: 7 years and older Common clinical indications: Routine adolescent and adult immunization Booster vaccination for tetanus and pertussis Wound management requiring tetanus protection Pregnancy-related pertussis protection (per guidelines) When to Use CPT 90715 CPT 90715 is appropriate when: A Tdap vaccine is administered to a patient 7 years or older The vaccine product is supplied by the provider Immunization is medically appropriate or preventive Administration is billed separately using the correct CPT code Examples: Administering a Tdap booster to an adult patient Vaccinating an adolescent according to routine immunization schedules Providing Tdap vaccination during pregnancy per clinical guidelines Documentation Requirements To support CPT 90715 billing, documentation should include: Patient identifiers and date of service Vaccine name (Tdap) and CPT code Manufacturer, lot number, and expiration date Route of administration and injection site Vaccine Information Statement (VIS) date provided Ordering and administering provider details Accurate documentation supports compliance, patient safety, and reimbursement
Temperature: In most cases where the dosage form is applied to skin, 32C is appropriate
Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M
These results suggest that medications targeting the bodys metabolic hormones could eventually become an option for treating alcohol use conditions
10.1523/JNEUROSCI.0426-16.2016 10 AlamZ
